BUZZ-三星支持在亚洲推出癌症检测产品后,Grail 跳涨

路透中文
Oct 16, 2025
BUZZ-<a href="https://laohu8.com/S/SMSN.UK">三星</a>支持在亚洲推出癌症检测产品后,Grail 跳涨

10月16日 - ** 癌症诊断测试制造商GrailGRAL.O股价盘前上涨16.3%至87.80美元

** 三星将向 GRAL (link) 投资 1.1 亿美元,将 Galleri 癌症检测试剂盒引入韩国 - co

** Galleri 是一种通过检测肿瘤脱落的异常 DNA 来筛查 50 多种癌症的血液测试 - GRAL

** 该公司称,三星电子028260.KS将牵头推出该产品;并计划在日本和新加坡推广该产品

** 三星电子005930.KS将探索与GRAL的技术合作,包括人工智能和健康数据整合

** 该公司称,交易预计将于 2026 年初完成,但需视条件而定

** 截至收盘,GRAL股价年累计上涨约323

(为便利非英文母语者,路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误,或未能包含所需语境,路透不保证自动化翻译文本的准确性,仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10